Depending on dose, firmonertinib shrank tumors in 43% to 68% of patients as a first treatment for EGFR PACC-mutant lung cancer in the phase 1b FURTHER trial.
|Articles|September 8, 2008
- Fall 2008
- Volume 7
- Issue 3
Web Exclusive: Preventing Breast Cancer
What you need to know about breast cancer prevention.
Advertisement
When it comes to preventing cancer, everyone can benefit from exercise, not smoking, and eating a healthy diet high in fruits and vegetables. But for people with a predisposition for breast cancer, such as those with genetic mutations and a family history, prevention strategies may need to be more specific.
Read CURE’s past coverage of the therapeutic options for preventing breast cancer in "
Articles in this issue
about 18 years ago
Message from the CURE Staffabout 18 years ago
Understanding Preventive Mastectomyabout 18 years ago
International Thyroid Cancer Survivors' Conferenceabout 18 years ago
Breaking Down TCMabout 18 years ago
Olympian Postpones Treatment to Competeabout 18 years ago
New Pharmacy Breed Offers Special Attention, Drawbacks to Patientsabout 18 years ago
www.SharingHope.tvabout 18 years ago
Q&A: Vitamin Dabout 18 years ago
Never Fearabout 18 years ago
Web Exclusive: How to Manage Side EffectsAdvertisement
Related to this article
Debbie Legault, whose daughter was diagnosed with breast cancer at 27, urges shoppers to skip pink ribbon products and donate directly to support organizations.
A study of 52,236 patients with cancer found that episodes of unintended weight loss affected 46.63% of patients and were tied to shorter overall survival.
Diagnosed with leukemia at 8 years old, Harper feared that losing her hair would change who she was. She reflects on body image, confidence and finding a sense of herself during cancer treatment.
A psycho-oncologist answers 5 common questions about cancer-related anxiety, depression, fear of recurrence and emotional well-being.
U.S. counties where more residents had medical debt in collections had higher rates of late-stage lung, head and neck, colorectal and several other cancers, according to a study of 2,958 counties published in October 2026 in JAMA Network Open.
Diagnosed with stage 4 breast cancer weeks after giving birth, Eileen Carter explains why getting a second opinion changed the course of her care.
Libtayo survival data, a rare positive osteosarcoma trial and new ADCs for breast, lung and stomach cancers are among ESMO 2026 abstracts to watch.
Advertisement
Advertisement
Trending on CURE
1
Stage 4 Breast Cancer: How a Second Opinion Saved Her Life
2
Psycho-Oncologist Answers 5 Common Questions About the Emotional Impact of Cancer
3
FDA Flags Possible Colitis Risk With CDK4/6 Breast Cancer Drugs
4
Why Biomarker Testing Can Change a Brain Tumor Diagnosis
5